Discovery through Machine Learning and Preclinical Validation of Novel Anti-Diabetic Peptides
While there have been significant advances in drug discovery for diabetes mellitus over the past couple of decades, there is an opportunity and need for improved therapies. While type 2 diabetic patients better manage their illness, many of the therapeutics in this area are peptide hormones with len...
Main Authors: | Rory Casey, Alessandro Adelfio, Martin Connolly, Audrey Wall, Ian Holyer, Nora Khaldi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/3/276 |
Similar Items
-
Peptide Array Based Discovery of Synthetic Antimicrobial Peptides
by: Chris W Diehnelt
Published: (2013-12-01) -
Natural Peptides in Drug Discovery Targeting Acetylcholinesterase
by: Vivitri Prasasty, et al.
Published: (2018-09-01) -
Sequence-Based Discovery of Antibacterial Peptides Using Ensemble Gradient Boosting
by: Ehdieh Khaledian, et al.
Published: (2020-12-01) -
Human milk and infant formulae: Peptide differences and the opportunity to address the functional gap
by: Cyril Lopez, et al.
Published: (2020-11-01) -
Precision-engineered Peptide and Protein Analogs: Establishing a New Discovery Platform for Potent GPCR Modulators
by: Kalyan Bharati Akondi, et al.
Published: (2021-06-01)